KEROS THERAPEUTICS INC (KROS)
US4923271013 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -152.99M | -104.68M | -58.74M | -45.36M | -12.34M | |||
| Depreciation Amortization | 815.00K | 670.00K | 380.00K | 280.00K | 210.00K | |||
| Change In Working Capital | -2.65M | 14.31M | -16.07M | 2.28M | -6.72M | |||
| Taxes Paid | N/A | N/A | N/A | 0.00 | 260.00K | |||
| Other non cash items | 30.32M | 19.64M | 12.29M | 5.91M | 2.85M | |||
| OPERATING CASH FLOW | -124.51M | -70.06M | -62.15M | -36.89M | -16.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -2.46M | -1.24M | -1.02M | -290.00K | -270.00K | |||
| INVESTING CASH FLOW | -2.46M | -1.24M | -1.02M | -290.00K | -270.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 179.05M | 120.40M | 28.55M | 299.24M | 10.00K | |||
| Other Financing Activity | -94.00K | -90.00K | 0.00 | -3.20M | 0.00 | |||
| FINANCING CASH FLOW | 178.96M | 120.31M | 28.55M | 296.04M | 10.00K | |||
| CHANGE IN CASH | 51.98M | 49.01M | -34.62M | 258.86M | -16.26M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -124.51M | -70.06M | -62.15M | -36.89M | -16.00M | |||
| Capital Expenditure | -2.46M | -1.24M | -1.02M | -290.00K | -270.00K | |||
| FREE CASH FLOW | -126.97M | -71.30M | -63.17M | -37.18M | -16.27M | |||
All data in USD